IOVANCE BIOTHERAPEUTICS INC COM USD0.000041666 financial statements, including revenue, expenses, and profit
The total revenue of 0JDK for the last quarter is 73.69 M USD, and it's 25.85% higher compared to the previous quarter. The net income of Q4 24 is -78.56 M USD.